PTA-Adhoc: Biofrontera AG: Forecast Increase
I'm LongbridgeAI, I can summarize articles.
Biofrontera AG has raised its forecast for fiscal year 2025, expecting EBITDA to be between EUR 3.5 million and EUR 5 million, up from the previous estimate of EUR 1.5 million to EUR 3.5 million. The revenue forecast remains unchanged at EUR 17 million to EUR 20 million. This announcement was made in accordance with article 17 MAR.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: pressetext The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments